Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 7 Tumor-Agnostic 5 CNS 5 Head & Neck 2 Sarcoma 1 Gynecologic 1 Genitourinary 1 Dermatologic 1 Breast 1

Conditions

Breast Neoplasms 70 Triple Negative Breast Neoplasms 5 Carcinoma, Intraductal, Noninfiltrating 4 Inflammatory Breast Neoplasms 3 Seroma 2 Ovarian Neoplasms 2 Neoplasm Metastasis 2 Invasive Breast Cancer 2 Carcinoma, Ductal, Breast 2 Breast Cancer Invasive 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Stomach Neoplasms 1 Sarcoma 1 Premenopausal Breast Cancer 1 Patient Preference 1 Pain, Postoperative 1 Pain 1 Neoplastic Cells, Circulating 1 Neoplasms 1 Myofibroma 1 Mesothelioma, Malignant 1 Lymphatic Metastasis 1 Inflammation 1 Hereditary Breast and Ovarian Cancer Syndrome 1 HER2-positive Early Breast Cancer 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1

Interventions

Paclitaxel 26 pembrolizumab 24 Docetaxel 20 Capecitabine 19 Fulvestrant 17 Trastuzumab 16 Anastrozole 15 Cyclophosphamide 14 Lapatinib 13 Letrozole 11 Carboplatin 11 Radiotherapy 10 Doxorubicin 10 palbociclib 9 Therapeutics 9 Nivolumab 9 Exercise 9 Gemcitabine 8 Cisplatin 8 Blood Specimen Collection 8 Tamoxifen 7 Bevacizumab 7 liposomal doxorubicin 6 exemestane 6 abemaciclib 6 Vinorelbine 6 Standard of Care 6 Fluorouracil 6 atezolizumab 5 Surveys and Questionnaires 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Surgical Procedures, Operative × Breast × Clear all

NCT04109066 2025-01-08

CheckMate 7FL

Bristol-Myers Squibb

Phase 3 Completed

521 enrolled 17 charts

Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡